Groups | EAC | MOE |
---|
Duration |
---|
Viability at week 1 | 71.80 ± 3.10a | 60.40 ± 1.90b |
Viability at week 2 | 69.30 ± 0.20a | 26.90 ± 2.70c |
- Values are presented as means (n = 14 mice/group) ± SE; different letter superscripts in the same row considered significant at (P ≤ 0.05)
- C Control, MOE Moringa seed oil extract, EAC Ehrlich ascites carcinoma, EAC/MOE Ehrlich ascites carcinoma treated with Moringa olifera oil extract